Figure 3

Dapt Review

KARACA Özkan*, KARASU Mehdi, KOBAT Mehmet A and KIVRAK Tarık

Published: 25 March, 2020 | Volume 5 - Issue 1 | Pages: 060-066

jccm-aid1088-g003

Figure 3:

Algorithm for dual antiplatelet therapy (DAPT) in patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention (PCI). Colour-coding refers to the number of concomitant antithrombotic medication(s). Triple therapy denotes treatment with DAPT plus oral anticoagulant (OAC). Dual therapy denotes treatment with a single antiplatelet agent (aspirin or clopidogrel) plus. ABC = age, biomarkers, clinical history; ACS = acute coronary syndrome; mo. = month(s); PCI = percutaneous coronary intervention. 1: Periprocedural administration of aspirin and clopidogrel during PCI is recommended irrespective of the treatment strategy. 2: High ischaemic risk is considered as an acute clinical presentation or anatomical/procedural features which might increase the risk for myocardial infarction. 3: Bleeding risk can be estimated by HAS-BLED or ABC score.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001088 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?